- Home
- LCFY vs CYCN Comparison
LCFY vs CYCN Comparison
Compare LCFY & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- CYCN
- Stock Information
- Founded
- LCFY 2009
- CYCN 2018
- Country
- LCFY Australia
- CYCN United States
- Employees
- LCFY N/A
- CYCN N/A
- Industry
- LCFY
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- LCFY
- CYCN Health Care
- Exchange
- LCFY Nasdaq
- CYCN Nasdaq
- Market Cap
- LCFY 9.9M
- CYCN 7.5M
- IPO Year
- LCFY 2022
- CYCN N/A
- Fundamental
- Price
- LCFY $5.22
- CYCN $2.53
- Analyst Decision
- LCFY
- CYCN
- Analyst Count
- LCFY 0
- CYCN 0
- Target Price
- LCFY N/A
- CYCN N/A
- AVG Volume (30 Days)
- LCFY 15.3K
- CYCN 72.9K
- Earning Date
- LCFY 04-30-2025
- CYCN 03-04-2025
- Dividend Yield
- LCFY N/A
- CYCN N/A
- EPS Growth
- LCFY N/A
- CYCN N/A
- EPS
- LCFY N/A
- CYCN N/A
- Revenue
- LCFY $2,668,385.00
- CYCN $2,000,000.00
- Revenue This Year
- LCFY N/A
- CYCN N/A
- Revenue Next Year
- LCFY N/A
- CYCN N/A
- P/E Ratio
- LCFY N/A
- CYCN N/A
- Revenue Growth
- LCFY N/A
- CYCN N/A
- 52 Week Low
- LCFY $2.20
- CYCN $1.27
- 52 Week High
- LCFY $11.23
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- LCFY 30.82
- CYCN 43.72
- Support Level
- LCFY $5.08
- CYCN $2.47
- Resistance Level
- LCFY $6.52
- CYCN $2.92
- Average True Range (ATR)
- LCFY 0.61
- CYCN 0.26
- MACD
- LCFY -0.13
- CYCN -0.00
- Stochastic Oscillator
- LCFY 12.71
- CYCN 35.21
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.